Eledon Pharmaceuticals Stock Price History
| ELDN Stock | USD 3.51 0.07 2.03% |
Below is the normalized historical share price chart for Eledon Pharmaceuticals extending back to September 17, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eledon Pharmaceuticals stands at 3.51, as last reported on the 22nd of March, with the highest price reaching 3.55 and the lowest price hitting 3.30 during the day.
If you're considering investing in Eledon Stock, it is important to understand the factors that can impact its price. Eledon Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0653, which denotes the company had a -0.0653 % return per unit of risk over the last 3 months. Eledon Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eledon Pharmaceuticals' Mean Deviation of 2.74, standard deviation of 3.56, and Variance of 12.68 to check the risk estimate we provide.
At this time, Eledon Pharmaceuticals' Common Stock Shares Outstanding is very stable compared to the past year. As of the 22nd of March 2025, Other Stockholder Equity is likely to grow to about 497.3 M, while Total Stockholder Equity is likely to drop about 66.1 M. . As of the 22nd of March 2025, Price To Sales Ratio is likely to drop to 149.02. In addition to that, Price Earnings Ratio is likely to drop to -5.95. Eledon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of September 2014 | 200 Day MA 3.4904 | 50 Day MA 4.2048 | Beta 0.808 |
Eledon |
Sharpe Ratio = -0.0653
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ELDN |
Estimated Market Risk
| 3.52 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eledon Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eledon Pharmaceuticals by adding Eledon Pharmaceuticals to a well-diversified portfolio.
Eledon Pharmaceuticals Stock Price History Chart
There are several ways to analyze Eledon Stock price data. The simplest method is using a basic Eledon candlestick price chart, which shows Eledon Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 3, 2025 | 4.83 |
| Lowest Price | March 20, 2025 | 3.44 |
Eledon Pharmaceuticals March 22, 2025 Stock Price Synopsis
Various analyses of Eledon Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eledon Stock. It can be used to describe the percentage change in the price of Eledon Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eledon Stock.| Eledon Pharmaceuticals Price Daily Balance Of Power | 0.28 | |
| Eledon Pharmaceuticals Price Action Indicator | 0.12 | |
| Eledon Pharmaceuticals Price Rate Of Daily Change | 1.02 |
Eledon Pharmaceuticals March 22, 2025 Stock Price Analysis
Eledon Stock Price History Data
The price series of Eledon Pharmaceuticals for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 1.39 with a coefficient of variation of 8.73. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.21. The median price for the last 90 days is 4.26. The company completed 1:18 stock split on 5th of October 2020. Eledon Pharmaceuticals completed dividends distribution on 2020-10-05.| Open | High | Low | Close | Volume | ||
03/22/2025 | 3.37 | 3.55 | 3.30 | 3.51 | ||
| 03/21/2025 | 3.37 | 3.55 | 3.30 | 3.51 | 302,104 | |
| 03/20/2025 | 3.54 | 3.63 | 3.43 | 3.44 | 534,315 | |
| 03/19/2025 | 3.54 | 3.63 | 3.52 | 3.56 | 126,943 | |
| 03/18/2025 | 3.60 | 3.66 | 3.53 | 3.54 | 172,668 | |
| 03/17/2025 | 3.64 | 3.71 | 3.55 | 3.63 | 195,192 | |
| 03/14/2025 | 3.59 | 3.70 | 3.52 | 3.65 | 111,621 | |
| 03/13/2025 | 3.73 | 3.75 | 3.57 | 3.60 | 176,784 | |
| 03/12/2025 | 3.70 | 3.82 | 3.55 | 3.75 | 256,672 | |
| 03/11/2025 | 3.60 | 3.72 | 3.51 | 3.69 | 206,980 | |
| 03/10/2025 | 3.80 | 3.80 | 3.58 | 3.59 | 406,890 | |
| 03/07/2025 | 3.85 | 3.97 | 3.74 | 3.79 | 349,997 | |
| 03/06/2025 | 3.85 | 4.01 | 3.76 | 3.81 | 145,000 | |
| 03/05/2025 | 3.88 | 3.97 | 3.82 | 3.94 | 146,383 | |
| 03/04/2025 | 3.93 | 3.98 | 3.80 | 3.89 | 301,600 | |
| 03/03/2025 | 4.20 | 4.29 | 3.96 | 4.01 | 395,500 | |
| 02/28/2025 | 4.07 | 4.18 | 3.96 | 4.15 | 141,996 | |
| 02/27/2025 | 4.26 | 4.44 | 4.06 | 4.08 | 176,600 | |
| 02/26/2025 | 4.15 | 4.32 | 4.12 | 4.26 | 164,326 | |
| 02/25/2025 | 4.11 | 4.19 | 4.01 | 4.14 | 197,300 | |
| 02/24/2025 | 4.47 | 4.47 | 4.16 | 4.16 | 151,132 | |
| 02/21/2025 | 4.32 | 4.39 | 4.23 | 4.29 | 147,600 | |
| 02/20/2025 | 4.50 | 4.50 | 4.33 | 4.34 | 157,679 | |
| 02/19/2025 | 4.63 | 4.65 | 4.45 | 4.51 | 189,290 | |
| 02/18/2025 | 4.58 | 4.63 | 4.46 | 4.59 | 194,300 | |
| 02/14/2025 | 4.53 | 4.58 | 4.40 | 4.53 | 111,648 | |
| 02/13/2025 | 4.52 | 4.55 | 4.44 | 4.49 | 122,160 | |
| 02/12/2025 | 4.28 | 4.54 | 4.28 | 4.50 | 202,900 | |
| 02/11/2025 | 4.44 | 4.68 | 4.30 | 4.33 | 221,178 | |
| 02/10/2025 | 4.72 | 4.77 | 4.46 | 4.52 | 255,800 | |
| 02/07/2025 | 4.75 | 4.97 | 4.61 | 4.70 | 374,563 | |
| 02/06/2025 | 4.67 | 4.85 | 4.55 | 4.75 | 209,187 | |
| 02/05/2025 | 4.67 | 4.83 | 4.61 | 4.71 | 150,100 | |
| 02/04/2025 | 4.46 | 4.68 | 4.40 | 4.67 | 229,100 | |
| 02/03/2025 | 4.52 | 4.64 | 4.40 | 4.46 | 173,100 | |
| 01/31/2025 | 4.78 | 4.82 | 4.48 | 4.52 | 282,000 | |
| 01/30/2025 | 4.74 | 4.86 | 4.60 | 4.78 | 247,700 | |
| 01/29/2025 | 4.74 | 4.78 | 4.56 | 4.74 | 300,300 | |
| 01/28/2025 | 4.82 | 4.85 | 4.51 | 4.75 | 399,500 | |
| 01/27/2025 | 4.41 | 4.67 | 4.39 | 4.66 | 452,800 | |
| 01/24/2025 | 4.26 | 4.48 | 4.17 | 4.43 | 230,500 | |
| 01/23/2025 | 4.20 | 4.28 | 4.04 | 4.25 | 127,322 | |
| 01/22/2025 | 4.10 | 4.28 | 4.08 | 4.21 | 227,068 | |
| 01/21/2025 | 4.04 | 4.11 | 3.99 | 4.09 | 150,743 | |
| 01/17/2025 | 4.03 | 4.04 | 3.90 | 4.02 | 151,368 | |
| 01/16/2025 | 4.06 | 4.19 | 3.87 | 4.03 | 232,752 | |
| 01/15/2025 | 3.79 | 4.07 | 3.71 | 4.05 | 990,875 | |
| 01/14/2025 | 3.92 | 4.00 | 3.68 | 3.71 | 368,355 | |
| 01/13/2025 | 4.01 | 4.05 | 3.77 | 3.89 | 391,372 | |
| 01/10/2025 | 4.25 | 4.25 | 4.00 | 4.04 | 234,020 | |
| 01/08/2025 | 4.60 | 4.66 | 4.27 | 4.30 | 258,624 | |
| 01/07/2025 | 4.66 | 4.66 | 4.40 | 4.51 | 208,917 | |
| 01/06/2025 | 4.88 | 4.88 | 4.58 | 4.64 | 280,168 | |
| 01/03/2025 | 4.27 | 4.98 | 4.26 | 4.83 | 659,057 | |
| 01/02/2025 | 4.19 | 4.67 | 4.16 | 4.29 | 540,260 | |
| 12/31/2024 | 4.16 | 4.20 | 4.00 | 4.12 | 377,143 | |
| 12/30/2024 | 4.35 | 4.35 | 4.02 | 4.14 | 760,296 | |
| 12/27/2024 | 4.31 | 4.40 | 4.20 | 4.35 | 514,172 | |
| 12/26/2024 | 4.27 | 4.38 | 4.10 | 4.37 | 563,100 | |
| 12/24/2024 | 4.17 | 4.31 | 4.03 | 4.27 | 262,279 | |
| 12/23/2024 | 4.31 | 4.36 | 4.00 | 4.19 | 441,974 |
About Eledon Pharmaceuticals Stock history
Eledon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eledon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eledon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eledon Pharmaceuticals stock prices may prove useful in developing a viable investing in Eledon Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 485.4 M | 509.7 M | |
| Net Loss | -31.1 M | -29.5 M |
Eledon Pharmaceuticals Quarterly Net Working Capital |
|
Eledon Pharmaceuticals Stock Technical Analysis
Eledon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Eledon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eledon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eledon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eledon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.01) | |||
| Treynor Ratio | (0.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.